Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Genetics and Cytogenetics

• Publication date

  2005-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CANCERGENCYTO.2005.04.003PMID 16213361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Genomic Hybridization Analysis of Genetic Alterations Associated with Malignant Progression of Meningioma

  2004cited by this paper
• Prognostic value of allelic losses and telomerase activity in meningiomas.

  2004cited by this paper
• Allele‐specific loss of heterozygosity at the DAL‐1/4.1B (EPB41L3) tumor‐suppressor gene locus in the absence of mutation

  2004cited by this paper
• Meningioma Pathology, Genetics, and Biology

  2004cited by this paper
• Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms

  2003cited by this paper
• The constitutional t(17;22): another translocation mediated by palindromic AT-rich repeats.

  2003cited by this paper
• Malignant Melanoma Classification and Gene Discovery in Mouse Models of Array Comparative Genome Hybridization for Tumor Updated

  2003cited by this paper
• A novel sequence-based approach to localize translocation breakpoints identifies the molecular basis of a t(4;22).

  2003cited by this paper
• Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization.

  2003cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.

  2002cited by this paper
• Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation‐induced human meningiomas

  2001cited by this paper
• Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

  2001cited by this paper
• NF2 status of meningiomas is associated with tumour localization and histology

  2001cited by this paper
• Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.

  2001cited by this paper
• Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.

  2000influential reference
• Frequent Loss of 1p32 Region but no Mutation if the p18 Tumor Suppressor Gene in Meningiomas

  2000cited by this paper
• Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.

  1999cited by this paper
• NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas

  1999cited by this paper
• Detection of gains and losses in 18 meningiomas by comparative genomic hybridization.

  1998cited by this paper
• Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast

  1998cited by this paper
• Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

  1994cited by this paper

• Crispr/Cas-based modeling of NF2 loss in meningioma cells.

  2021cites this paper
• Tumors of the Anterior Visual Pathways

  2021cites this paper
• Meningiomas: Comprehensive Strategies for Management

  2020influential citation
• Comprehensive Treatment Strategies for Spinal Meningiomas

  2020cites this paper
• Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition

  2020cites this paper
• Meningioma: A Review of Clinicopathological and Molecular Aspects

  2020cites this paper
• Molecular characteristics of meningiomas

  2020cites this paper
• Key Word and Full-Text Search Genomic Characterization of Meningiomas

  2019cites this paper
• Pivotal roles of protein 4.1B/DAL‑1, a FERM‑domain containing protein, in tumor progression (Review).

  2019cites this paper
• Advances in meningioma genetics: novel therapeutic opportunities

  2018cites this paper
• Neurofibromatosis and Schwannomatosis

  2018cites this paper
• Expression of Matrix Metalloproteinase-2 and -9 in Meningioma

  2018cites this paper
• Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma.

  2018cites this paper
• A Review of the Histologic, Genetic and Molecular Characteristics of Meningioma Pathogenesis and Progression

  2017cites this paper
• Cellular prion protein (PrPC) in the development of Merlin-deficient tumours

  2017cites this paper
• PrP contributes to increased proliferation, cell-matrix adhesion and survival in schwannoma cells acting via 37/67kDa non-integrin laminin receptor (LR/37/67kDa) and downstream ERK1/2, PI3K/AKT and FAK signalling pathways. PrP protein is also strongly released from schwannoma cells via exosomes and

  2017cites this paper
• Genetic and epigenetic alterations in meningiomas.

  2017cites this paper
• Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.

  2016cites this paper
• Drug Resistance in Malignant Meningiomas

  2016cites this paper
• Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

  2016cites this paper
• Case-Based Review: meningioma.

  2016cites this paper
• Clinicopathological Study of Meningioma

  2016cites this paper
• Patterns of protein expression and cytogenetic alterations in meningiomas: relationship with the clinical and biological features of the disease

  2015cites this paper
• Genetic/molecular alterations of meningiomas and the signaling pathways targeted

  2015cites this paper
• Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental models.

  2015cites this paper
• EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas

  2015cites this paper
• Méningiomes intracrâniens

  2015cites this paper
• Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

  2015cites this paper
• Glutamatergic Synapse Formation in Developing Zebrafish Embryos

  2015cites this paper
• A literature review of key molecular genetic aberrations in meningiomas: a potential role in the determination of radiosurgery outcomes.

  2014cites this paper
• Tumor suppressor role of protein 4.1B/DAL-1

  2014cites this paper
• Most frequent molecular and immunohistochemical markers present in selected types of brain tumors.

  2014cites this paper
• Cranial Meningioma in Neurofi bromatosis Type 2 Patients: Role of Mutations

  2014cites this paper
• Meningiomas of the Craniovertebral Junction: A Review

  2013cites this paper
• Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

  2013cites this paper
• Current standing and frontiers of gene therapy for meningiomas.

  2013cites this paper
• Spinal cord tumours: advances in genetics and their implications for treatment

  2013cites this paper
• Analysis of Gene Expression Pattern and Neuroanatomical Correlates for SLC20A2 (PiT-2) Shows a Molecular Network with Potential Impact in Idiopathic Basal Ganglia Calcification (“Fahr’s Disease”)

  2013cites this paper
• Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.

  2012cites this paper
• Badania kliniczno-molekularne w oponiakach

  2012cites this paper
• Genomic Characterization of Meningiomas

  2012cites this paper
• Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.

  2011cites this paper
• Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation*

  2011cites this paper
• The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.

  2011cites this paper
• The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments

  2011cites this paper
• Pathological classification and molecular genetics of meningiomas

  2010cites this paper
• CHAPTER 8 – Molecular Biology and Genetics of Meningiomas

  2010cites this paper
• In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma

  2010cites this paper
• Gene Expression Profiles of Meningiomas are Associated with Tumor Cytogenetics and Patient Outcome

  2009cites this paper
• The Future of Molecular Neuro-Oncology

  2009cites this paper
• Expression of the Tumor Suppressor Genes NF2, 4.1B, and TSLC1 in Canine Meningiomas

  2009cites this paper
• Molecular Basis of Meningioma Tumorigenesis and Progression

  2009cites this paper
• - Catenin Signaling Pathway β Wnt / Reducing E-Cadherin and Activating the Meningiomas Promotes Tumor Growth by Downregulated MicroRNA-200 a in

  2009cites this paper
• A role for the p53 pathway in the pathology of meningiomas with NF2 loss

  2009cites this paper
• Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/β-Catenin Signaling Pathway

  2009cites this paper
• Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas

  2009cites this paper
• Histology and Molecular Genetics

  2008cites this paper
• Microarray gene expression profiling in meningiomas and schwannomas.

  2008cites this paper
• Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas

  2008cites this paper
• Preliminary analysis of genomic abnormalities in canine meningiomas.

  2008cites this paper
• Potential role of EPB41L3 (Protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer

  2008cites this paper
• Short communication Characterization of complex chromosome aberrations in a recurrent meningioma combining standard cytogenetic and array comparative genomic hybridization techniques

  2008cites this paper
• Gene Expression Profiles in Human Lymphocytes Irradiated In Vitro with Low Doses of Gamma Rays

  2007cites this paper
• Molecular genetics of meningiomas: from basic research to potential clinical applications.

  2007cites this paper
• Mutational spectrum of the NF2 gene: a meta‐analysis of 12 years of research and diagnostic laboratory findings

  2007cites this paper
• Diagnostic and molecular pathology of meningiomas

  2006cites this paper
• Histological classification and molecular genetics of meningiomas.

  2006cites this paper
• Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma

  2005cites this paper